BIOPOR: BioPorto A/S - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

BioPorto A/S

DNK:BIOPOR

SummaryFactSheetFinancial
Price
kr1.28
Loss Chance
54.2%
2.91JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Biotechnology
1 / 5
Health Care
7 / 19
Denmark
?
49 / 124
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Bavarian Nordic A/S
DNK:BAVA
3.51
kr209.40
75.29%
Genmab A/S
DNK:GMAB
5.59
kr2,151.00
148.79%
H. Lundbeck A/S
DNK:HLUN A
7.40
kr40.50
5.64%
H. Lundbeck A/S
DNK:HLUN B
7.40
kr41.04
4.38%
Strategic Partners A/S
DNK:STRAP
2.84
kr700.00
100.00%
Jitta Factors
Growth Opportunity (46)
Recent Business Performance (57)
Financial Strength (26)
Return to Shareholders (0)
Competitive Advantage (53)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
SG&A to SalesDecreasing
Cash Conversion CycleLess than 60 days
Revenue and EarningEarning loss detected in 2025
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.91
100.00%
3.53
76.74%
4.64
69.38%
Biotechnology
3.51
75.29%
5.59
148.79%
2.84
100.00%
COMPANY DESCRIPTION
BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI); NGAL Test, a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma, or heparin plasma on automated clinical chemistry analyzers to diagnose acute kidney injury; and antibodies to develop diagnostic immunoassays within disease areas, including immunodeficiency, allergy, coagulation, diabetes, kidney, and cardiovascular disease. The company also provides ready-to-use enzyme-linked immunosorbent assay (ELISA) kits to quantify NGAL in urine, plasma, and serum; and generic Rapid Assay Device (gRAD) for custom lateral flow assays. BioPorto A/S was founded in 1917 and is based in Hellerup, Denmark.
bioporto.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.